Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

100 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Incidence of risk factors for bloodstream infections in patients with major burns receiving intensive care: A retrospective single-center cohort study.
Fochtmann-Frana A, Freystätter C, Vorstandlechner V, Barth A, Bolliger M, Presterl E, Ihra G, Muschitz G, Mittlboeck M, Makristathis A, Rath T, Radtke C, Forstner C. Fochtmann-Frana A, et al. Among authors: bolliger m. Burns. 2018 Jun;44(4):784-792. doi: 10.1016/j.burns.2017.12.009. Epub 2018 Feb 1. Burns. 2018. PMID: 29395408
Re: Comment on "Incidence of risk factors for bloodstream infections in patients with major burns receiving intensive care: A retrospective single-center cohort study".
Fochtmann-Frana A, Freystätter C, Vorstandlechner V, Barth A, Bolliger M, Presterl E, Ihra G, Muschitz G, Mittlboeck M, Makristathis A, Rath T, Radtke C, Forstner C. Fochtmann-Frana A, et al. Among authors: bolliger m. Burns. 2019 May;45(3):744-745. doi: 10.1016/j.burns.2018.12.008. Epub 2018 Dec 24. Burns. 2019. PMID: 30591250 No abstract available.
The iTOP trial: Comparing immediate techniques of oncoplastic surgery with conventional breast surgery in women with breast cancer - A prospective, controlled, single-center study.
Bolliger M, Lanmüller P, Schuetz M, Heilig B, Windischbauer A, Jakesz R, Zehetgruber T, Gnant M, Gleiss A, Dörfler D, Singer C, Bartsch R, Haslik W, Montagna G, Fitzal F. Bolliger M, et al. Int J Surg. 2022 Aug;104:106694. doi: 10.1016/j.ijsu.2022.106694. Epub 2022 Jun 1. Int J Surg. 2022. PMID: 35662621 Free PMC article. Clinical Trial.
Retrospective, Multicenter Analysis Comparing Conventional with Oncoplastic Breast Conserving Surgery: Oncological and Surgical Outcomes in Women with High-Risk Breast Cancer from the OPBC-01/iTOP2 Study.
Fitzal F, Bolliger M, Dunkler D, Geroldinger A, Gambone L, Heil J, Riedel F, de Boniface J, Andre C, Matrai Z, Pukancsik D, Paulinelli RR, Ostapenko V, Burneckis A, Ostapenko A, Ostapenko E, Meani F, Harder Y, Bonollo M, Alberti ASM, Tausch C, Papassotiropoulos B, Helfgott R, Heck D, Fehrer HJ, Acko M, Schrenk P, Trapp EK, Gunda PT, Clara P, Montagna G, Ritter M, Blohmer JU, Steffen S, Romics L, Morrow E, Lorenz K, Fehr M, Weber WP. Fitzal F, et al. Among authors: bolliger m. Ann Surg Oncol. 2022 Feb;29(2):1061-1070. doi: 10.1245/s10434-021-10809-1. Epub 2021 Oct 13. Ann Surg Oncol. 2022. PMID: 34647202 Free PMC article.
[No title available]
[No authors listed] [No authors listed] PMID: 34676460
Optimal duration of adjuvant endocrine therapy: how to apply the newest data.
Wimmer K, Strobl S, Bolliger M, Devyatko Y, Korkmaz B, Exner R, Fitzal F, Gnant M. Wimmer K, et al. Among authors: bolliger m. Ther Adv Med Oncol. 2017 Nov;9(11):679-692. doi: 10.1177/1758834017732966. Epub 2017 Oct 27. Ther Adv Med Oncol. 2017. PMID: 29344105 Free PMC article. Review.
Duration of Adjuvant Aromatase-Inhibitor Therapy in Postmenopausal Breast Cancer.
Gnant M, Fitzal F, Rinnerthaler G, Steger GG, Greil-Ressler S, Balic M, Heck D, Jakesz R, Thaler J, Egle D, Manfreda D, Bjelic-Radisic V, Wieder U, Singer CF, Melbinger-Zeinitzer E, Haslbauer F, Sevelda P, Trapl H, Wette V, Wimmer K, Gampenrieder SP, Bartsch R, Kacerovsky-Strobl S, Suppan C, Brunner C, Deutschmann C, Soelkner L, Fesl C, Greil R; Austrian Breast and Colorectal Cancer Study Group. Gnant M, et al. N Engl J Med. 2021 Jul 29;385(5):395-405. doi: 10.1056/NEJMoa2104162. N Engl J Med. 2021. PMID: 34320285 Clinical Trial.
Adjuvant Bisphosphonate Therapy in Postmenopausal Breast Cancer.
Strobl S, Wimmer K, Exner R, Devyatko Y, Bolliger M, Fitzal F, Gnant M. Strobl S, et al. Among authors: bolliger m. Curr Treat Options Oncol. 2018 Mar 12;19(4):18. doi: 10.1007/s11864-018-0535-z. Curr Treat Options Oncol. 2018. PMID: 29527635 Review.
100 results